Fukuda, Y.; Sakurada, Y.; Kotoda, Y.; Kimura, M.; Kashiwagi, K.
Comparison of Three Consecutive Monthly Administrations Between Aflibercept 8 mg and Brolucizumab 6 mg in Polypoidal Choroidal Vasculopathy. Pharmaceuticals 2025, 18, 1811.
https://doi.org/10.3390/ph18121811
AMA Style
Fukuda Y, Sakurada Y, Kotoda Y, Kimura M, Kashiwagi K.
Comparison of Three Consecutive Monthly Administrations Between Aflibercept 8 mg and Brolucizumab 6 mg in Polypoidal Choroidal Vasculopathy. Pharmaceuticals. 2025; 18(12):1811.
https://doi.org/10.3390/ph18121811
Chicago/Turabian Style
Fukuda, Yoshiko, Yoichi Sakurada, Yumi Kotoda, Misa Kimura, and Kenji Kashiwagi.
2025. "Comparison of Three Consecutive Monthly Administrations Between Aflibercept 8 mg and Brolucizumab 6 mg in Polypoidal Choroidal Vasculopathy" Pharmaceuticals 18, no. 12: 1811.
https://doi.org/10.3390/ph18121811
APA Style
Fukuda, Y., Sakurada, Y., Kotoda, Y., Kimura, M., & Kashiwagi, K.
(2025). Comparison of Three Consecutive Monthly Administrations Between Aflibercept 8 mg and Brolucizumab 6 mg in Polypoidal Choroidal Vasculopathy. Pharmaceuticals, 18(12), 1811.
https://doi.org/10.3390/ph18121811